Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F72NW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,091
Award facts
- Contract value 100% obligated
- $4,091.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,091.04 on November 25, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in pharmaceutical procurement for military and veteran healthcare systems. The company's portfolio encompasses a broad range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor with extensive federal contracting experience through the DLA's Medical Supply Chain, AmerisourceBergen serves defense health system customers including the Defense Health Agency and U.S. Coast Guard. The award of this delivery order reflects the contractor's demonstrated capability to fulfill federal medical supply requirements and its established role as a key provider within the military healthcare logistics framework.
Quick answers
Who was awarded contract SPE2DR26F72NW?
SPE2DR26F72NW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F72NW worth?
The government has obligated $4,091 on SPE2DR26F72NW.
Is contract SPE2DR26F72NW an order under another contract?
Yes. SPE2DR26F72NW is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72NW competed?
The extent of competition for SPE2DR26F72NW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award